The BCR-ABL1-like ALL includes leukemias with functionally distinct classes of genetic aberrations (such as ABL versus JAK/STAT class) resulting in a nonnegligible biological but also clinical heterogeneity of this ALL subtype. This evidence concerns the gene BCR and acute lymphoblastic leukemia.